Rein Therapeutics Inc. (RNTX) Ownership

$1.40

$0.04 (-2.78%)
Last update: 04:00 PM EST
Day's range
$1.41
Day's range
$1.46

Rein Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BIOS CAPITAL MANAGEMENT, LP 05/14/2025 1.69 M $2.99 M   0.00% 7,793.99%
VOSS CAPITAL, LLC 05/14/2025 990.72 K $1.75 M   3.61% 4,566.98%
VANGUARD GROUP INC 05/09/2025 716.79 K $1.27 M   68.66% 3,304.24%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 05/07/2025 511.61 K $905.55 K   -17.10% 2,358.41%
PROSIGHT MANAGEMENT, LP 05/15/2025 430.00 K $761.10 K   6.18% 1,982.21%
CABLE CAR CAPITAL LLC 05/15/2025 420.00 K $743.40 M   0.00% 1,936.11%
SIGMA PLANNING CORP 05/02/2025 305.18 K $540.16 K   29.20% 1,406.79%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 246.10 K $435.72 K   1.93% 1,134.45%
SENVEST MANAGEMENT, LLC 05/14/2025 230.90 K $408.68 K   0.00% 1,064.38%
GAGNON SECURITIES LLC 05/09/2025 71.75 K $126.99 K   0.00% 330.73%
ROYAL BANK OF CANADA 05/15/2025 57.26 K $101.00 K   -46.47% 263.94%
BLACKROCK, INC. 05/02/2025 51.30 K $90.81 K   -35.02% 236.50%
CHICAGO PARTNERS INVESTMENT GROUP LLC 05/09/2025 35.91 K $58.54 K   100.00% 165.55%
EXENCIAL WEALTH ADVISORS, LLC 05/09/2025 30.53 K $54.04 K   0.00% 140.73%
MERIDIAN WEALTH ADVISORS, LLC 05/05/2025 28.49 K $50.42 K   100.00% 131.31%
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC 05/14/2025 26.17 K $46.32 K   0.00% 120.64%
NORTHERN TRUST CORP 05/13/2025 25.76 K $45.60 K   0.00% 118.76%
BLAIR WILLIAM & CO/IL 05/09/2025 23.62 K $41.81 K   -7.73% 108.89%
KCK LTD. 07/11/2025 22.34 K $39.54 K   0.00% 102.99%
KG&L CAPITAL MANAGEMENT,LLC 04/23/2025 18.00 K $31.86 K   0.00% 82.98%
TWO SIGMA SECURITIES, LLC 05/15/2025 16.27 K $28.80 K   100.00% 75.01%
STATE STREET CORP 05/15/2025 16.00 K $28.33 K   0.00% 73.78%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 05/14/2025 15.44 K $27.33 K   100.00% 71.18%
NEWBRIDGE FINANCIAL SERVICES GROUP, INC. 05/15/2025 11.19 K $19.81 K   100.00% 51.60%
AMERICANA PARTNERS, LLC 05/12/2025 11.10 K $19.65 K   100.00% 51.18%
MORGAN STANLEY 05/15/2025 4.30 K $7.61 K   0.00% 19.82%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 3.46 K $6.12 K   33.99% 15.94%
UBS GROUP AG 05/13/2025 2.98 K $5.28 K   -58.90% 13.74%
JFS WEALTH ADVISORS, LLC 04/22/2025 1.59 K $2.82 K   0.00% 7.33%
US BANCORP \DE\ 05/08/2025 1.25 K $2.21 K   0.00% 5.76%
BANK OF AMERICA CORP /DE/ 05/15/2025 241 $427   -15.14% 1.11%
HEXAGON CAPITAL PARTNERS LLC 04/29/2025 213 $377   0.00% 0.98%
ADVISOR GROUP HOLDINGS, INC. 05/12/2025 140 $248   100.00% 0.65%
JPMORGAN CHASE & CO 05/12/2025 32 $57   6.67% 0.15%
GAME PLAN FINANCIAL ADVISORS, LLC 05/19/2025 25 $44   0.00% 0.12%
RONALD BLUE TRUST, INC. 04/21/2025 20 $35   100.00% 0.09%
WELLS FARGO & COMPANY/MN 05/13/2025 2 $4   100.00% 0.01%

Rein Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 35 institutional investors and hedge funds held shares of Rein Therapeutics Inc.. The most heavily invested institutionals were:

BIOS Capital Management, LP: 1.69 M

Voss Capital, LLC: 990,716

VANGUARD GROUP INC: 716,788

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO: 511,610

Prosight Management, LP: 430,000

Cable Car Capital LLC: 420,000

27,739.00% of Rein Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 5.98 M shares in the last 24 months. This purchase volume represents approximately $8.43 M in transactions.